Global Veterinary Anti-infectives Market size and share are currently valued at USD 8.57 billion in 2024 and is anticipated to generate an estimated revenue of USD 15.71 Billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 6.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034

In recent years, the market has experienced consistent growth due to advancements in veterinary medicine, the introduction of new-generation anti-infective formulations, and increased investments in animal healthcare infrastructure. According to industry estimates, the market is expected to witness robust expansion over the next decade, supported by greater emphasis on preventive healthcare, increased veterinary expenditure, and supportive government initiatives aimed at promoting responsible antimicrobial use.

However, the market faces challenges related to antimicrobial resistance (AMR) and stringent regulatory frameworks. The increasing restriction on the use of antibiotics as growth promoters in livestock has compelled market players to focus on innovation, developing alternatives such as vaccines and novel antimicrobial agents. Despite these challenges, the overall trajectory of the veterinary anti-infectives market remains positive, with innovation and policy alignment driving its sustainable growth.

Market Growth Drivers

1. Rising Incidence of Infectious Diseases in Animals
   One of the foremost factors propelling the market is the increasing occurrence of infectious diseases among livestock and companion animals. Conditions such as bovine respiratory disease, foot-and-mouth disease, avian influenza, and leptospirosis are significant concerns in both developing and developed economies. These outbreaks not only threaten animal welfare but also lead to substantial economic losses in the livestock sector, prompting higher demand for effective anti-infective solutions.
2. Growing Global Livestock Population and Protein Consumption
   The expanding global population and the surging demand for animal protein have led to an increase in livestock farming. As intensive farming practices become more common, the risk of infectious disease transmission among densely housed animals has grown considerably. Consequently, the reliance on anti-infective products to maintain herd health and productivity has strengthened.
3. Increasing Pet Ownership and Veterinary Care Expenditure
   The pet care industry has witnessed remarkable growth, particularly in emerging economies where disposable income levels are rising. Pet owners are increasingly aware of preventive healthcare and are willing to spend on high-quality veterinary services. This trend has directly contributed to the rising demand for anti-infective products used to treat infections in companion animals such as dogs, cats, and horses.
4. Technological Advancements and Product Innovation
   Innovation in drug formulation and delivery systems has significantly transformed the veterinary anti-infectives landscape. Controlled-release formulations, combination therapies, and species-specific drugs have enhanced treatment outcomes while reducing side effects. Additionally, the integration of digital technologies and diagnostics in veterinary practice has enabled early detection of infections, facilitating timely anti-infective administration.
5. Supportive Government Policies and Animal Health Programs
   Governments and international organizations, such as the World Health Organization (WHO) and the World Organisation for Animal Health (OIE), have initiated numerous programs to combat infectious diseases in animals. Public–private collaborations aimed at improving access to veterinary care, especially in rural regions, are further stimulating market growth.

Key Market Trends

1. Shift Toward Preventive Healthcare and Antimicrobial Stewardship
   A significant shift is taking place from reactive treatments to preventive care in animal health management. With rising concerns about antimicrobial resistance, stakeholders are emphasizing prudent use of antibiotics and promoting vaccines and immune-boosting supplements as alternatives. This trend aligns with the broader global movement toward responsible antibiotic use to ensure long-term efficacy of anti-infective agents.
2. R&D Investments in Next-Generation Anti-Infectives
   Pharmaceutical and biotechnology companies are heavily investing in research to discover new classes of anti-infectives that are effective against resistant pathogens. The exploration of peptide-based antimicrobials, bacteriophages, and plant-derived compounds is gaining traction as sustainable solutions to address resistance challenges.
3. Growing Use of Combination Therapies
   Combination therapies, involving two or more active agents, are being increasingly adopted to enhance the spectrum of activity and minimize the development of resistance. This approach has proven particularly effective in treating mixed infections and complex bacterial diseases in livestock.
4. Rising Demand for Organic and Antibiotic-Free Animal Products
   Consumer preference for organic, antibiotic-free meat and dairy products has encouraged producers to adopt more regulated and traceable infection-control methods. This has led to increased adoption of alternative anti-infective solutions such as probiotics, herbal antimicrobials, and vaccination programs.
5. Emergence of Digital and Diagnostic Integration
   Technological integration in veterinary care—such as remote monitoring, rapid diagnostic kits, and AI-driven disease surveillance—has enabled veterinarians to detect infections earlier and administer targeted anti-infective treatments. This digital evolution is optimizing drug use, reducing wastage, and improving treatment outcomes.

Research Scope

The scope of research in the veterinary anti-infectives market is expanding beyond conventional antibiotics. Modern studies are focused on understanding microbial resistance mechanisms and developing sustainable interventions that align with the “One Health” concept, which recognizes the interconnectedness of human, animal, and environmental health.

Key research areas include:

• Novel Antimicrobial Agents: Development of new molecules with unique mechanisms of action.
• Antimicrobial Resistance Studies: Genetic mapping and surveillance of resistance trends to guide policy and practice.
• Alternative Therapies: Exploration of bacteriophages, probiotics, and herbal extracts as substitutes or complements to traditional anti-infectives.
• Drug Delivery Innovations: Development of long-acting injectable formulations and targeted delivery systems.
• Zoonotic Disease Prevention: Research linking veterinary anti-infective use to human health outcomes in zoonotic disease control.

Moreover, collaborations between academic institutions, government bodies, and pharmaceutical companies are fostering a fertile environment for innovation and knowledge exchange. Such partnerships are expected to accelerate the discovery and commercialization of safer, more efficient anti-infective products.

Major Key Players:

• Biogénesis Bagó S.A.
• Boehringer Ingelheim GmbH
• Calier S.A.
• Ceva Santé Animale S.A.
• Dechra Pharmaceuticals Plc.
• Elanco Animal Health Incorporated
• Intervet International B.V. (a subsidiary of Merck & Co., Inc.)
• Merck & Co., Inc.
• Norbrook Laboratories Ltd.
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.
• Bayer AG
• Bimeda Animal Health Limited

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/veterinary-anti-infectives-market

Market Segmentation

The veterinary anti-infectives market can be segmented based on product type, animal type, route of administration, distribution channel, and region.

1. By Product Type:

• Antibacterial Agents: The largest segment, driven by high demand in treating bacterial infections in livestock.
• Antiviral Agents: Gaining traction due to rising awareness of viral diseases such as avian influenza and canine parvovirus.
• Antifungal Agents: Used for fungal infections in companion animals and poultry.
• Antiparasitic Agents: Increasingly popular for managing internal and external parasites in cattle, poultry, and pets.

• Livestock (Cattle, Swine, Poultry, Sheep & Goats): Dominant segment due to large-scale commercial farming and meat production.
• Companion Animals (Dogs, Cats, Horses): Rapidly growing segment, supported by higher pet adoption rates and increased pet care spending.

• Oral: Widely preferred for ease of administration in both livestock and pets.
• Injectable: Preferred for severe infections requiring rapid systemic action.
• Topical: Used primarily for skin and wound infections.

• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Feed Stores and Distributors

• North America: Leading market due to advanced veterinary infrastructure, high animal healthcare expenditure, and established pharmaceutical industry.
• Europe: Strongly regulated market emphasizing antimicrobial stewardship and animal welfare.
• Asia-Pacific: Fastest-growing region due to expanding livestock population, economic development, and government-backed animal health initiatives.
• Latin America & Middle East & Africa: Emerging markets with increasing awareness and investments in animal health infrastructure.

Conclusion

The veterinary anti-infectives market stands at a critical juncture where innovation, policy, and sustainability intersect. The rising demand for animal-derived food products, growing pet ownership, and persistent threat of infectious diseases are ensuring sustained demand for effective anti-infective solutions. However, the industry must balance growth with responsibility—adopting antimicrobial stewardship, investing in R&D for novel therapies, and promoting preventive care.

As the world advances toward a more integrated “One Health” approach, the veterinary anti-infectives market will play a central role in ensuring both animal and human health security. With continuous innovation, regulatory support, and evolving consumer awareness, the market is poised to remain a vital and dynamic segment of the global healthcare ecosystem.

More Trending Latest Reports By Polaris Market Research:

Virtual Reality Market

Slider Bags Market

Chainsaw Market

point of purchase packaging market

Slider Bags Market

Acai Berry Market

Technical Textiles Market

Inulin Market

RF Interconnect Market